ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2025

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system.

Silvia Fenix-Caballero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.